Physician profile
Sa Wang
NPI 1093798845
$27,122.70
in general payments reported to CMS, 2019-2025
6 companies · $3,028 in 2025
The $3,028 reported for 2025 was more than what 80% of Hematology (Pathology) providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $5,820 · 2022: $4,443 · 2024: $149 · 2025: $3,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,028 · Education: $85.00 · Food and Beverage: $63.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,028.00 |
| Education | $85.00 |
| Food and Beverage | $63.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $9,390.50 | 2020-2025 | Ayvakit |
| Amgen INC. | $8,040.00 | 2019 | |
| Stemline Therapeutics INC. | $5,610.39 | 2019 | |
| Glaxosmithkline, LLC. | $3,900.00 | 2020 | |
| Alexion Pharmaceuticals, INC. | $148.67 | 2024 | Soliris, Ultomiris |
| Seagen INC. | $33.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sa Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.